Mixed Carcinoma — Trials

Mixed Carcinoma — Trials · CancerIndex

Clinical trials

Registered studies

119 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 37
Recruiting: 13
Ph III recruiting: 5
Growth YoY: —
Industry share: 16%
Top sponsor: National Cancer Institute (NCI)
Termination share: 21.1%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (14)

clinicaltrialsPublishedShowing 51–59 of 59 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT00570674	Abraxane in Combination With Carboplatin, Erbitux and IMRT for Locally Advanced Squamous Cancer of the Head and Neck	terminated	Phase 1 / Phase 2	29	Dana-Farber Cancer InstituteOTHER	0	Nov 13, 2017	clinicaltrials
NCT00039442	Capecitabine in Treating Patients With Persistent or Recurrent Cervical Cancer	completed	Phase 2	21	Gynecologic Oncology GroupNETWORK	1	Aug 24, 2017	clinicaltrials